Thalassemia Treatment Market to Showcase High Growth; to cross USD 1548 MN Mark by 2026
Posted On May 09, 2020
The report by Value Market Research on the Global Thalassemia Treatment Market anticipates the market growth to reach CAGR of 7% during 2020-2026. The market was valued close to USD 964 MN in 2019 and is expected to reach USD 1548 MN by 2026. An upsurge in awareness about the disorder and technological developments are most likely to encourage the adoption of gene therapies. Global Thalassemia Treatment Market is anticipated to flourish owing to the rising prevalence of the disorder, growth in pharma R&D investments, rising health-care expenses, and, a surge in the Asian population. Thalassemia treatment is primarily restricted to blood transfusions and iron chelation therapy. Additionally, the treatment involves the use of sophisticated clinical and preclinical imaging systems that implies higher operation and maintenance cost, thus restraining the global thalassemia treatment.
Thalassemia is a congenital blood disorder, which is inherited from either parent wherein the body either makes abnormal form or an inadequate amount of hemoglobin. In this disorder, a large number of red blood cells get destroyed, which leads to anemia. Primarily, a patient suffers from this order if there is a defect in a gene that helps control the production of either Alpha globin or Beta Globin. Thalassemia treatment is dependent on the type and severity of the condition. Most commonly, three procedures are used for treating this disorder blood transfusion, bone marrow transplantation cholecystectomy. The most common symptoms of this disorder are fatigue, pale skin, facial bone deformities, abdominal swelling, nasty dark colored urine, lack of hunger, and greater susceptibility to infections.
The elaborate study "Global Thalassemia Treatment Market Report By Type (Alpha Thalassemia And Beta Thalassemia), Class (Iron Chelating Drugs And Gene Therapy) End-User (Hospital, Research Institute, Laboratories And Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026" poses a refreshing view of the market taking into consideration all the aspects affecting the market. The contents of the report talks about historic data along with throwing light on the future opportunities of the thalassemia treatment market.
On the basis of type the thalassemia treatment market is bifurcated into alpha thalassemia and beta thalassemia. By class the thalassemia treatment market is bifurcated into iron chelating drugs and gene therapy. On the basis of end-user the thalassemia treatment market is bifurcated into hospital, research institute, laboratories and clinics.
Geographically the research study provides data on North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. This section provides the estimates of market by segment. This section provides the estimates of market by segment thus, providing valuable data to take strategic decisions.
The Report Segments Global Thalassemia Treatment Market -
- Alpha Thalassemia
- Beta Thalassemia
- Iron Chelating Drugs
- Gene Therapy
- Research Institute
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Players Profiled In the Report:
Acceleron Pharma, Inc., Bluebird Bio, Inc., GlaxoSmithKline plc., Incyte Corporation, IONIS Pharmaceuticals, Kiadis Pharma, La Jolla Pharmaceutical Company, Lonza Group Ltd. and Sangamo Bioscience among others.
Download the FREE SAMPLE of Global Thalassemia Treatment Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]